Search research articles
Contact Us
Filters
Showing results (81-90 of 96) with videos related to
Page
of 10
Sort By:
EMBO Molecular Medicine
|
May 2, 2026
Spatially resolved ex vivo drug response profiling in SMARCB1-deficient sinonasal carcinoma
Philipp Jurmeister, Susanne Flach, Linda Bergmayr, et al.
Biorxiv : the Preprint Server for Biology
|
October 17, 2024
BRAF/MEK Inhibition Induces Cell State Transitions Boosting Immune Checkpoint Sensitivity in BRAFV600E -mutant Glioma
Yao Lulu Xing, Dena Panovska, Jong-Whi Park, et al.
Cell Reports. Medicine
|
June 12, 2025
BRAF/MEK inhibition induces cell state transitions boosting immune checkpoint sensitivity in BRAF<sup>V600E</sup>-mutant glioma
Yao Lulu Xing, Dena Panovska, Jong-Whi Park, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
November 17, 2025
Clinical potential of [<sup>18</sup>F]FET PET in patients with circumscribed astrocytic glioma
Jan-Michael Werner, Maximilian J Mair, Michael M Wollring, et al.
Neuro-Oncology Advances
|
January 6, 2022
Preclinical and clinical evaluation of German-sourced ONC201 for the treatment of H3K27M-mutant diffuse intrinsic pontine glioma
Ryan J Duchatel, Abdul Mannan, Ameha S Woldu, et al.
Epilepsia
|
March 1, 2025
Seizure outcomes following epilepsy surgery in pediatric and young adult patients with high-grade brain tumors: Results from a European survey
Robert Lersch, Till Hartlieb, Tom Pieper, et al.
Science Advances
|
October 27, 2023
Deciphering sources of PET signals in the tumor microenvironment of glioblastoma at cellular resolution
Laura M Bartos, Sabrina V Kirchleitner, Zeynep Ilgin Kolabas, et al.
Neuro-Oncology
|
November 18, 2024
Alternative lengthening of telomere-based immortalization renders H3G34R-mutant diffuse hemispheric glioma hypersensitive to PARP inhibitor combination regimens
Anna Laemmerer, Christian Lehmann, Lisa Mayr, et al.
Nature Cancer
|
May 26, 2025
Cellular hierarchies of embryonal tumors with multilayered rosettes are shaped by oncogenic microRNAs and receptor-ligand interactions
Alexander Beck, Lisa Gabler-Pamer, Gustavo Alencastro Veiga Cruzeiro, et al.
Research Square
|
July 3, 2026
Combinatorial Targeting of Avapritinib-Driven MAP Kinase Activation in High-Grade Glioma
Carl Koschmann, Kallen Schwark, Kelsey Wink, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 96) with videos related to
Sort By:
Page
of 10
EMBO Molecular Medicine
|
May 2, 2026
Spatially resolved ex vivo drug response profiling in SMARCB1-deficient sinonasal carcinoma
Philipp Jurmeister, Susanne Flach, Linda Bergmayr, et al.
Biorxiv : the Preprint Server for Biology
|
October 17, 2024
BRAF/MEK Inhibition Induces Cell State Transitions Boosting Immune Checkpoint Sensitivity in BRAFV600E -mutant Glioma
Yao Lulu Xing, Dena Panovska, Jong-Whi Park, et al.
Cell Reports. Medicine
|
June 12, 2025
BRAF/MEK inhibition induces cell state transitions boosting immune checkpoint sensitivity in BRAF<sup>V600E</sup>-mutant glioma
Yao Lulu Xing, Dena Panovska, Jong-Whi Park, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
November 17, 2025
Clinical potential of [<sup>18</sup>F]FET PET in patients with circumscribed astrocytic glioma
Jan-Michael Werner, Maximilian J Mair, Michael M Wollring, et al.
Neuro-Oncology Advances
|
January 6, 2022
Preclinical and clinical evaluation of German-sourced ONC201 for the treatment of H3K27M-mutant diffuse intrinsic pontine glioma
Ryan J Duchatel, Abdul Mannan, Ameha S Woldu, et al.
Epilepsia
|
March 1, 2025
Seizure outcomes following epilepsy surgery in pediatric and young adult patients with high-grade brain tumors: Results from a European survey
Robert Lersch, Till Hartlieb, Tom Pieper, et al.
Science Advances
|
October 27, 2023
Deciphering sources of PET signals in the tumor microenvironment of glioblastoma at cellular resolution
Laura M Bartos, Sabrina V Kirchleitner, Zeynep Ilgin Kolabas, et al.
Neuro-Oncology
|
November 18, 2024
Alternative lengthening of telomere-based immortalization renders H3G34R-mutant diffuse hemispheric glioma hypersensitive to PARP inhibitor combination regimens
Anna Laemmerer, Christian Lehmann, Lisa Mayr, et al.
Nature Cancer
|
May 26, 2025
Cellular hierarchies of embryonal tumors with multilayered rosettes are shaped by oncogenic microRNAs and receptor-ligand interactions
Alexander Beck, Lisa Gabler-Pamer, Gustavo Alencastro Veiga Cruzeiro, et al.
Research Square
|
July 3, 2026
Combinatorial Targeting of Avapritinib-Driven MAP Kinase Activation in High-Grade Glioma
Carl Koschmann, Kallen Schwark, Kelsey Wink, et al.
Page
of 10